Advertisement

Topics

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $3500

09:12 EDT 13 Oct 2018 | BioPortfolio Reports

Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2018


Summary


Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R pipeline Target constitutes close to 6 molecules. The latest report Adrenocorticotropic Hormone Receptor Pipeline Review, H2 2018, outlays comprehensive information on the Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type.


Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R The adrenocorticotropic hormone receptor also known as the melanocortin receptor 2 is a type of melanocortin receptor type 2 which is specific for ACTH. ACTH receptor is found in the zona fasciculata of adrenal cortex. Binding of the receptor by ACTH stimulates the production of cortisol.


The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1, 2 and 1 respectively. Report covers products from therapy areas Central Nervous System, Metabolic Disorders, Genetic Disorders and Musculoskeletal Disorders which include indications Infantile Spasm West Syndrome, Pituitary ACTH Hypersecretion Cushing Disease, Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Gouty Arthritis Gout and Multiple Sclerosis.


Furthermore, this report also reviews key players involved in Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R

The report reviews Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics and enlists all their major and minor projects

The report assesses Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Adrenocorticotropic Hormone Receptor Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...